Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Store lyophilized at 20C
"B vitamin status, dietary intake and length of stay in a sample of elderly rehabilitation patients"
View AOD-9604 The peptide was developed by Metabolic Pharmaceuticals (Melbourne, Australia) specifically to isolate the fat-metabolism activity of the GH C-terminal domain while avoiding the growth-promoting and insulin-sensitizing effects of full-length GH
Statements Author contributions QH: Writing original draft, Writing review & editing
PMID: 24667154
Ipamorelin was originally developed by company Novo Nordisk, and was investigated in phase II clinical trials by Helsinn Therapeutics for treatment of postoperative ileus
